While OptimizeRx Corp has underperformed by -3.57%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OPRX fell by -0.90%, with highs and lows ranging from $22.25 to $3.99, whereas the simple moving average fell by -15.47% in the last 200 days.
On January 08, 2025, RBC Capital Mkts Downgraded OptimizeRx Corp (NASDAQ: OPRX) to Sector Perform. A report published by Stephens on December 20, 2024, Initiated its previous ‘Equal-Weight’ rating for OPRX. B. Riley Securities also rated OPRX shares as ‘Buy’, setting a target price of $18.50 on the company’s shares in an initiating report dated July 25, 2024. JMP Securities Initiated an Mkt Outperform rating on April 04, 2024, and assigned a price target of $15. Barclays initiated its ‘Equal Weight’ rating for OPRX, as published in its report on January 03, 2024. B. Riley Securities’s report from February 02, 2023 suggests a price prediction of $30 for OPRX shares, giving the stock a ‘Buy’ rating. Stifel also rated the stock as ‘Buy’.
Analysis of OptimizeRx Corp (OPRX)
Further, the quarter-over-quarter increase in sales is 22.33%, showing a positive trend in the upcoming months.
OptimizeRx Corp’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of 0.03% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.05, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and OPRX has an average volume of 270.08K. On a monthly basis, the volatility of the stock is set at 5.71%, whereas on a weekly basis, it is put at 7.48%, with a loss of -7.67% over the past seven days. Furthermore, long-term investors anticipate a median target price of $24.33, showing growth from the present price of $12.15, which can serve as yet another indication of whether OPRX is worth investing in or should be passed over.
How Do You Analyze OptimizeRx Corp Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 16.76%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 76.27% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
